NEW YORK (GenomeWeb News) – Cancer Genetics said today its genomic test for triaging cervical cancer patients has received approval in the US as a lab-developed test under Clinical Laboratory Improvement Amendments regulations.
Researchers from the Dana Farber Cancer Institute have published results of a preliminary study tracking the patterns of mutations in the two histological subtypes of cervical cancer, which they are now planning to put to the test in a clinical trial of PI3 kinase inhibitors.
NEW YORK (GenomeWeb News) – Officials from the National Institutes of Health and the family of Henrietta Lacks have together developed a policy for allowing researchers to access whole-genome data from HeLa cell lines, which was
In Lancet Respiratory Medicine, an international team led by investigators at the Duke University Medical Center described findings from a prospective study looking at asthma-related information that can be
NEW YORK (GenomeWeb News) – Molecular diagnostics company IncellDx today announced a deal with Chinese esoteric reference laboratory Kindstar Global to offer IncellDx's test for detecting oncogenic human papillomavirus PV E6, E7 messenger RNA in China.
Diagnostics company OncoHealth recently presented three studies demonstrating the ability of its protein biomarkers HPV, E6, and E7 to distinguish between insignificant human papillomavirus infections and those that could lead to cervical cancer.
NEW YORK (GenomeWeb News) – As it awaits completion of its $3.7 billion buy of Gen-Probe, Hologic reported after the close of the market on Monday that its diagnostics business segment grew 11 percent year over yea